Cancer Treatment Reviews
Volume 31, Supplement 2 , Pages S26-S33, 2005

The future of fulvestrant (‘Faslodex’)

CRUK Department of Medical Oncology, University of Manchester, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK

published online 04 October 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(05)00143-X

doi:10.1016/j.ctrv.2005.08.007

Cancer Treatment Reviews
Volume 31, Supplement 2 , Pages S26-S33, 2005

Article Tools

* Image Usage & Resolution